Factors associated with response to methylphenidate in advanced cancer patients

Oncologist

Volumn 16, Issue 2, 2011, Pages 246-253

  Yennurajalingam, Sriram ^a   Palmer, J Lynn ^a   Chacko, Ray ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer related fatigue; Methylphenidate; Predictors of response; Response to methylphenidate

Indexed keywords

METHYLPHENIDATE; OPIATE;

ADULT; ADVANCED CANCER; ANOREXIA; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BREAST CANCER; CANCER FATIGUE; CAUCASIAN; CONTROLLED STUDY; DEPRESSION; DIGESTIVE SYSTEM CANCER; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG RESPONSE; DRUG TOLERABILITY; EDMONTON SYMPTOM ASSESSMENT SYSTEM; FEMALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; INSOMNIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RESTLESSNESS; SCORING SYSTEM; SEDATION; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SLURRED SPEECH; TACHYCARDIA; UROGENITAL TRACT CANCER; VERTIGO;

ANOREXIA; ANXIETY; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; DRUG MONITORING; DYSPNEA; FATIGUE; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; NAUSEA; NEOPLASM STAGING; NEOPLASMS; PAIN; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP STAGES; TREATMENT OUTCOME;

EID: 79952583407     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0214     Document Type: Article

References (27)

1. Vogelzang NJ, Breitbart W, Cella D et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34(suppl 2):4-12.
2. Bruera E, Neumann C, Brenneis C et al. Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals. J Palliat Care 2000; 16:16-21.
3. National Comprehensive Cancer Network. Cancer Related Fatigue. Clinical Practice Guidelines in Oncology. Fort Washington, PA: National Comprehensive Cancer Network, 2007.
4. Lawrence DP, Kupelnick B, Miller K et al. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004;32:40-50.
5. Cella D, Peterman A, Passik S et al. Progress toward guidelines for the managementof fatigue. Oncology (Williston Park) 1998;12:369-377.
6. Cella D, Davis K, Breitbart W et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:3385-3391.
7. Barnes EA, Bruera E. Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer 2002;12:424-428.
8. Minton O, Stone P, Richardson A et al. Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev 2008;1:CD006704.
9. Minton O, Richardson A, Sharpe M et al. A systematic review and metaanalysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 2008;100:1155-1166.
10. Fleishman S, Lower E, Zeldis J et al. A phase II, randomized, placebocontrolled trial of the safety and efficacy of dexmethylphenidate (d-MPH) as a treatment for fatigue and "chemobrain" in adult cancer patients. Breast Cancer Res Treat 2005;94:S214.
11. Schwartz AL, Thompson JA, Masood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum 2002;29:E85-E90.
12. Bruera E, Miller MJ, MacMillan K et al. Neuropsychological effect of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 1992;48:163-166.
13. Homsi J, Nelson KA, Sarhill N et al. A phase II study of methylphenidate for depression in advanced cancer. Am J Hospice Palliat Care 2001;18: 403-407.
14. Bruera E, Fainsinger R et al. The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. Pain 1992;50:75-77.
15. Yennurajalingam S, Bruera E. Palliative Management of Fatigue at the Close of Life: "It Feels Like My Body Is Just Worn Out". JAMA 2007;297: 295-304.
16. Bruera E, Driver L, Barnes EA et al. Patient-controlled methylphenidate forthe management of fatigue in patients with advanced cancer. J Clin Oncol 2003;21:4439-4443.
17. Bruera E, Valero V, Driver L et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073-2078.
18. Bruera E, Kuehn N, Miller MJ et al. The Edmonton Symptom Assessment System (ESAS). J Palliat Care 1991;7:6-9.
19. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 2000;88:2164-2171.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
21. Bruera E, Miller L, McCallion J et al. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 1992;7:192-195.
22. Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Evanston, IL: Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, 1997.
23. Cella D, Tulsky DS, Gray G et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579.
24. Cella D. Functional Assessment of Cancer Therapy. Available at www.facit.org, accessed January 26, 2011.
25. Yennu S, Urbauer DL, Hui D et al. Factors associated with fatigue and predictors of improvement of fatigue in patients with advanced cancer [abstract 06-060]. Support Care Cancer. 2009;17:857-1039.
26. Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H et al. Prediction ofclinical response to methylphenidate in children with attention-deficit hyperactivitydisorder. J Am Acad Child Adolesc Psychiatry 1995;34:1025-1032.
27. Peterson K, McDonagh MS, Fu R. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) 2008;197:1-11.